Tumor matrix protein collagen XIα1 in cancer
Z Raglow, SM Thomas - Cancer letters, 2015 - Elsevier
The extracellular matrix is increasingly recognized as an essential player in cancer
development and progression. Collagens are one of the most important components of the …
development and progression. Collagens are one of the most important components of the …
[HTML][HTML] Targeting glycans for CAR therapy: the advent of sweet CARs
Z Raglow, MK McKenna, CL Bonifant, W Wang… - Molecular Therapy, 2022 - cell.com
Chimeric antigen receptor (CAR) T cell therapy has created a paradigm shift in the treatment
of hematologic malignancies but has not been as effective toward solid tumors. For such …
of hematologic malignancies but has not been as effective toward solid tumors. For such …
[HTML][HTML] SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
Background: Prolonged SARS-CoV-2 infections in immunocompromised hosts may predict
or source the emergence of highly mutated variants. The types of immunosuppression …
or source the emergence of highly mutated variants. The types of immunosuppression …
[HTML][HTML] Targeted disruption of pi–pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity
…, A Boonen, L Zhang, B Kalveram, Z Raglow… - Scientific reports, 2021 - nature.com
Lectins, carbohydrate-binding proteins, have been regarded as potential antiviral agents, as
some can bind glycans on viral surface glycoproteins and inactivate their functions. However…
some can bind glycans on viral surface glycoproteins and inactivate their functions. However…
Antimicrobial stewardship in solid organ transplant recipients: current challenges and proposed metrics
Background Solid organ transplant (SOT) recipients are challenging populations for antimicrobial
stewardship interventions due to a variety of reasons, including immunosuppression, …
stewardship interventions due to a variety of reasons, including immunosuppression, …
[HTML][HTML] SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis
Z Raglow, D Surie, JD Chappell, Y Zhu… - The Lancet …, 2024 - thelancet.com
Background Prolonged SARS-CoV-2 infections in people who are immunocompromised
might predict or source the emergence of highly mutated variants. The types of …
might predict or source the emergence of highly mutated variants. The types of …
IL 28B genotype and the expression of ISG s in normal liver
Z Raglow, C Thoma‐Perry, R Gilroy… - Liver …, 2013 - Wiley Online Library
Background & Aims Both polymorphisms in the IL 28B gene locus and ISG expression levels
are associated with the outcome of hepatitis C virus ( HCV ) infection. The two are also …
are associated with the outcome of hepatitis C virus ( HCV ) infection. The two are also …
Outpatient treatment for COVID-19
Z Raglow, PN Malani, LA Petty - JAMA, 2023 - jamanetwork.com
Who Is Eligible for Outpatient COVID-19 Medications? Individuals who test positive for SARS-CoV-2
and have COVID-19 symptoms are eligible for outpatient COVID-19 medications if …
and have COVID-19 symptoms are eligible for outpatient COVID-19 medications if …
A new antiviral option for cytomegalovirus prevention after kidney transplant
Z Raglow, DR Kaul - JAMA, 2023 - jamanetwork.com
Cytomegalovirus (CMV) is among the most consequential infections affecting solid organ
transplant recipients. In addition to the direct consequences of viral infection, the …
transplant recipients. In addition to the direct consequences of viral infection, the …
The interaction between HCV and nuclear receptor-mediated pathways
Z Raglow, C Thoma-Perry, R Gilroy, YJY Wan - Pharmacology & …, 2011 - Elsevier
Hepatitis C virus (HCV) is presently the leading indication for liver transplantation in Western
countries. Treatment for HCV infection includes a combination of pegylated interferon and …
countries. Treatment for HCV infection includes a combination of pegylated interferon and …